Calpain Inhibitor AK295 Protects Neurons From Focal Brain Ischemia: Effects of Postocdusion Intra-arterial Administration
暂无分享,去创建一个
R. Bartus | J. Powers | R. Dean | S. Harbeson | N. Hayward | P. Elliott | K. L. Baker | J. A. Straub | S. Sawyer | Z. Li | A. Akiyama | Sean D. Sawyer
[1] D. Choi,et al. Glutamate neurotoxicity and diseases of the nervous system , 1988, Neuron.
[2] R. Bartus,et al. Postischemic Administration of AK275, a Calpain Inhibitor, Provides Substantial Protection against Focal Ischemic Brain Damage , 1994, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[3] G. Lynch,et al. Brain fodrin: substrate for calpain I, an endogenous calcium-activated protease. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[4] T. Miyatake,et al. Suppressive effect of E-64c on ischemic degradation of cerebral proteins following occlusion of the middle cerebral artery in rats , 1990, Brain Research.
[5] R. Bartus. Drugs to Treat Age‐Related Neurodegenerative Problems The Final Frontier of Medical Science? , 1990, Journal of the American Geriatrics Society.
[6] G. Lynch,et al. Inhibition of proteolysis protects hippocampal neurons from ischemia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[7] G. Lynch,et al. Calpain inhibitors improve the recovery of synaptic transmission from hypoxia in hippocampal slices , 1990, Brain Research.
[8] H. Hori,et al. Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases. , 1993, Journal of medicinal chemistry.
[9] S. Harbeson,et al. Stereospecific synthesis of peptidyl alpha-keto amides as inhibitors of calpain. , 1994, Journal of medicinal chemistry.
[10] G. Lynch,et al. Intrahippocampal colchicine injection results in spectrin proteolysis , 1989, Neuroscience.
[11] G. Zelenock,et al. Morphometric evaluation of brain infarcts in rats and gerbils. , 1986, Journal of pharmacological methods.
[12] R. Jope,et al. Degradation of Microtubule‐Associated Protein 2 and Brain Spectrin by Calpain: A Comparative Study , 1991, Journal of neurochemistry.
[13] B. Siesjö. Cell Damage in the Brain: A Speculative Synthesis , 1981, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[14] L. Pitts,et al. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. , 1986, Stroke.
[15] KEVIN S. Lee,et al. Neuroprotection With a Calpain Inhibitor in a Model of Focal Cerebral Ischemia , 1994, Stroke.
[16] B. Meldrum. Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitters. , 1985, Clinical science.
[17] R. Mellgren,et al. Intracellular Calcium-Dependent Proteolysis , 1990 .
[18] E. Hogan,et al. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. , 1986, Stroke.